Pear Therapeutics, Inc.
Pear Therapeutics, Inc. (PEAR) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 70 transactions totaling $5.8M, demonstrating a bearish sentiment with -$5.8M in net insider flow. The most recent transaction on Apr 10, 2023 involved a sale of 534,855 shares valued at $64.2K.
PEAR Insider Activity Summary
Who Is Buying PEAR Stock?
No significant insider buying has been recorded for PEAR in the recent period.
Who Is Selling PEAR Stock?
No significant insider selling has been recorded for PEAR in the recent period.
Is Pear Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PEAR is bearish with an Insider Alignment Score of 0/100 and a net flow of -$5.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PEAR Frequently Asked Questions
Understanding PEAR Insider Activity
Insider trading at Pear Therapeutics, Inc. (PEAR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading PEAR stock, having executed 70 transactions in the past 90 days. The most active insider is Andrew J. Schwab (Executive), who has made 10 transactions totaling $2.7M.
Related Tools
Track Pear Therapeutics, Inc. Insider Activity
Get notified when executives and directors at PEAR file new Form 4 transactions